GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enlivex Therapeutics Ltd (FRA:1BT) » Definitions » Cyclically Adjusted Book per Share

Enlivex Therapeutics (FRA:1BT) Cyclically Adjusted Book per Share : €21.13 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Enlivex Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Enlivex Therapeutics's adjusted book value per share for the three months ended in Dec. 2023 was €1.483. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €21.13 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Enlivex Therapeutics's average Cyclically Adjusted Book Growth Rate was -1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-24), Enlivex Therapeutics's current stock price is €1.31. Enlivex Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €21.13. Enlivex Therapeutics's Cyclically Adjusted PB Ratio of today is 0.06.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Enlivex Therapeutics was 0.17. The lowest was 0.00. And the median was 0.00.


Enlivex Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Enlivex Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlivex Therapeutics Cyclically Adjusted Book per Share Chart

Enlivex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 23.81 21.13

Enlivex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.81 22.18 22.51 22.03 21.13

Competitive Comparison of Enlivex Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Enlivex Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enlivex Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enlivex Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enlivex Therapeutics's Cyclically Adjusted PB Ratio falls into.



Enlivex Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enlivex Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.483/129.4194*129.4194
=1.483

Current CPI (Dec. 2023) = 129.4194.

Enlivex Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.000 99.695 0.000
201406 7.792 100.560 10.028
201409 72.841 100.428 93.869
201412 69.926 99.070 91.348
201503 72.971 99.621 94.798
201506 62.941 100.684 80.905
201509 55.369 100.392 71.379
201512 46.273 99.792 60.011
201603 50.936 100.470 65.612
201606 33.634 101.688 42.806
201609 24.725 101.861 31.414
201612 20.125 101.863 25.569
201703 14.302 102.862 17.995
201706 10.060 103.349 12.598
201709 7.523 104.136 9.350
201712 6.395 104.011 7.957
201803 0.000 105.290 0.000
201806 3.179 106.317 3.870
201809 0.000 106.507 0.000
201812 19.192 105.998 23.433
201903 1.207 107.251 1.456
201906 1.344 108.070 1.610
201909 1.211 108.329 1.447
201912 0.983 108.420 1.173
202003 2.161 108.902 2.568
202006 1.991 108.767 2.369
202009 1.797 109.815 2.118
202012 2.000 109.897 2.355
202103 4.158 111.754 4.815
202106 4.090 114.631 4.618
202109 4.085 115.734 4.568
202112 4.106 117.630 4.518
202203 3.838 121.301 4.095
202206 3.525 125.017 3.649
202209 3.471 125.227 3.587
202212 2.913 125.222 3.011
202303 2.544 127.348 2.585
202306 2.201 128.729 2.213
202309 1.954 129.860 1.947
202312 1.483 129.419 1.483

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Enlivex Therapeutics  (FRA:1BT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enlivex Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.31/21.13
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Enlivex Therapeutics was 0.17. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Enlivex Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Enlivex Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Enlivex Therapeutics (FRA:1BT) Business Description

Industry
Traded in Other Exchanges
Address
14 Einstein Street, Nes Ziona, ISR, 7403618
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Enlivex Therapeutics (FRA:1BT) Headlines

No Headlines